Alliqua BioMedical Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
21,976.90
25,445.40
26,017.00
28,243.00
25,707.00
Depreciation, Depletion & Amortization
674.20
1,080.30
2,867.00
4,162.00
5,415.00
Other Funds
-
668.80
471.00
2,627.00
840.00
Funds from Operations
5,736.80
13,429.90
19,080.00
20,803.00
9,762.00
Changes in Working Capital
967.80
138.40
2,542.00
2,468.00
910.00
Net Operating Cash Flow
4,769.00
13,291.50
21,622.00
18,335.00
10,672.00
Capital Expenditures
118.10
339.90
423.00
893.00
179.00
Sale of Fixed Assets & Businesses
-
-
-
4,103.00
3,411.00
Net Investing Cash Flow
118.10
2,339.50
15,371.00
2,210.00
3,882.00
Issuance/Reduction of Debt, Net
-
-
14,244.00
1,748.00
1,618.00
Net Financing Cash Flow
16,727.30
20,301.20
46,302.00
4,375.00
3,391.00
Net Change in Cash
11,840.20
4,670.30
9,309.00
20,500.00
3,399.00
Free Cash Flow
4,820.40
13,298.10
22,045.00
19,228.00
10,851.00
Deferred Taxes & Investment Tax Credit
9.00
14.00
1,718.00
715.00
743.00
Net Assets from Acquisitions
-
1,999.50
14,948.00
-
-
Other Sources
-
-
-
-
1,000.00
Change in Capital Stock
16,727.30
20,970.00
32,529.00
-
5,849.00
Other Uses
-
-
-
1,000.00
350.00
About Alliqua BioMedical
View Profile
